Voriconazole Tablet Franchise in Ahmedabad

Antifungal Tablet Supplier in Mumbai

Fungal Infection Medicine Distributor in Delhi

Antifungal Pharma Franchise in Bangalore

Voriconazole Tablet Stockist in Hyderabad
Antifungal Tablet Manufacturer & Exporter in Chandigarh

Home/Products /voriconazole-400mg-tablet

Voricole 400 Tablet

Composition : Voriconazole (400mg) Tablet

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10x7

Price : ₹1/-

Voricole 400 Tablet contains Voriconazole 400mg, a high-strength triazole antifungal agent used in the treatment of severe and invasive fungal infections. It is commonly utilized in advanced care settings where potent antifungal coverage is required.

Voriconazole works by inhibiting the synthesis of ergosterol, an essential component of the fungal cell membrane. This action disrupts fungal cell integrity, effectively stopping fungal growth and aiding in infection control.

This tablet is widely used for managing invasive aspergillosis, serious candidal infections, and other systemic fungal conditions, particularly in patients with weakened immune systems or those requiring intensive antifungal therapy.

Voricole 400 Tablet is valued for its strong clinical performance, broad antifungal spectrum, and dependable therapeutic outcomes. Its role in treating life-threatening fungal infections makes it an important part of advanced antifungal treatment protocols.

Read More

About the Product

Voricole 400 Tablet contains Voriconazole 400mg, a high-strength triazole antifungal agent used in the treatment of severe and invasive fungal infections. It is commonly utilized in advanced care settings where potent antifungal coverage is required.

Voriconazole works by inhibiting the synthesis of ergosterol, an essential component of the fungal cell membrane. This action disrupts fungal cell integrity, effectively stopping fungal growth and aiding in infection control.

This tablet is widely used for managing invasive aspergillosis, serious candidal infections, and other systemic fungal conditions, particularly in patients with weakened immune systems or those requiring intensive antifungal therapy.

Voricole 400 Tablet is valued for its strong clinical performance, broad antifungal spectrum, and dependable therapeutic outcomes. Its role in treating life-threatening fungal infections makes it an important part of advanced antifungal treatment protocols.

Common side effects may include nausea, vomiting, abdominal discomfort, headache, dizziness, and visual disturbances such as blurred vision or altered color perception. Serious side effects may include liver function abnormalities, photosensitivity reactions, skin rashes, or cardiac rhythm disturbances. Medical attention is advised if severe reactions occur.

Voricole 400 Tablet is indicated for the treatment of invasive aspergillosis, serious Candida infections, esophageal candidiasis, and other life-threatening fungal infections, particularly in immunocompromised patients or those not responding to conventional antifungal treatment.

Voricole 400 Tablet should be taken strictly as prescribed, usually on an empty stomach. Regular monitoring of liver function and vision is recommended during prolonged therapy. Avoid direct sunlight and tanning devices due to the risk of photosensitivity. Inform your doctor about all ongoing medications to prevent drug interactions.

Store Voricole 400 Tablet in a cool, dry place away from direct sunlight and moisture. Keep the tablets in their original packaging and out of reach of children. Do not use after the expiry date mentioned on the pack.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation